Evidence map›Paper›PMID 34425016›Full record

ArticleActa anaesthesiologica Scandinavica2022

Oxygenation targets in ICU patients with COVID-19: A post hoc subgroup analysis of the HOT-ICU trial.

Bodil S Rasmussen, Thomas L Klitgaard, Anders Perner, Björn A Brand, Thomas Hildebrandt, Martin Siegemund, Alexa Hollinger, Søren R Aagaard, Morten H Bestle, Klaus V Marcussen and 12 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03174002 (Handling Oxygenation Targets in Adults With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit), which is not on this map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03174002 phase4completednot on this map

Handling Oxygenation Targets in Adults With Acute Hypoxaemic Respiratory Failure in the Intensive Care Unit: A Randomised Clinical Trial of a Lower Versus a Higher Oxygenation Target

TypeinterventionalSponsorAalborg University HospitalRan2017 to 2021Enrolled2,928ConditionsHypoxemic Respiratory Failure, Oxygen ToxicityArmsOxygen
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Oxygen therapy in the intensive care unit.Medical gas research · 2025
    Review
  4. Article
  5. Article
  6. Changing the culture of chaos.Acta anaesthesiologica Scandinavica · 2025
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 13 institutions in 5 countries.

Bodil S RasmussenDepartment of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0003-2190-145X
Thomas L KlitgaardDepartment of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.
Anders PernerCenter for Research in Intensive Care, Rigshospitalet, Copenhagen, Denmark.
Björn A BrandDepartment of Intensive Care, Rigshospitalet, University of Copenhagen, Denmark.
Thomas HildebrandtDepartment of Anaesthesia and Intensive Care, Zealand University Hospital, Roskilde, Denmark.
Martin SiegemundDepartment of Anaesthesia and Intensive Care, Basel University Hospital, Basel, Switzerland.
Alexa HollingerDepartment of Anaesthesia and Intensive Care, Basel University Hospital, Basel, Switzerland.ORCID 0000-0001-6799-1652
Søren R AagaardDepartment of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.
Morten H BestleDepartment of Anaesthesia and Intensive Care, Nordsjaellands Hospital, Hilleroed, Denmark.
Klaus V MarcussenDepartment of Anaesthesia and Intensive Care, Slagelse Hospital, Slagelse, Denmark.
Anne C BrøchnerDepartment of Anaesthesia and Intensive Care, Kolding Hospital, Kolding, Denmark.
Christoffer G SøllingDepartment of Anaesthesia and Intensive Care, Viborg Hospital, Viborg, Denmark.
Lone M PoulsenDepartment of Anaesthesia and Intensive Care, Zealand University Hospital, Køge, Denmark.
Jon H LaakeDepartment of Anaesthesia and Intensive Care, Oslo University Hospital Rikshospitalet, Oslo, Norway.
Tayyba N AslamDepartment of Anaesthesia and Intensive Care, Oslo University Hospital Rikshospitalet, Oslo, Norway.ORCID 0000-0002-1376-1533
Minna BäcklundDepartment of Anaesthesia and Intensive Care, Helsinki University Hospital, Helsinki, Finland.
Marjatta OkkonenDepartment of Anaesthesia and Intensive Care, Helsinki University Hospital, Helsinki, Finland.
Matthew MorganDepartment of Intensive Care, University Hospital of Wales, Cardiff, UK.
Mike SharmanDepartment of Intensive Care and Respiratory Medicine, Manchester University NHS Foundation Trust, Manchester Royal Infirmary, Manchester, UK.
Theis LangeSection of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Jørn WetterslevCopenhagen Trial Unit, Copenhagen, Denmark.
Olav L SchjørringDepartment of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.ORCID 0000-0002-7749-6003
Aalborg University Hospital · DKUniversity of Copenhagen · DKHelsinki University Hospital · FIOslo University Hospital · NOUniversity of Basel · CHKolding Hospital · DKManchester Royal Infirmary · GBNordsjællands Hospital · DKRegionshospitalet Viborg · DKSlagelse Hospital · DKUniversity Hospital of Wales · GBZealand University Hospital · DKZealand University Hospital Køge · DK

Funding

Det Obelske Familiefond 27970Innovationsfonden 4108-00011ARegions of Denmark EMN-2017-00901Regions of Denmark EMN-2019-01055
6 · The paper itself

Abstract

backgroundSupplemental oxygen is the key intervention for severe and critical COVID-19 patients. With the unstable supplies of oxygen in many countries, it is important to define the lowest safe dosage.

methodsIn spring 2020, 110 COVID-19 patients were enrolled as part of the Handling Oxygenation Targets in the ICU trial (HOT-ICU). Patients were allocated within 12 h of ICU admission. Oxygen therapy was titrated to a partial pressure of arterial oxygen (PaO

resultsAt 90 days, 22 of 54 patients (40.7%) in the lower oxygenation group and 23 of 55 patients (41.8%) in the higher oxygenation group had died (adjusted risk ratio: 0.87; 95% confidence interval, 0.58-1.32). The percentage of days alive without life support was significantly higher in the lower oxygenation group (p = 0.03). The numbers of severe ischemic events were low with no difference between the two groups. Proning and inhaled vasodilators were used more frequently, and the positive end-expiratory pressure was higher in the higher oxygenation group. Tests for interactions with the results of the remaining HOT-ICU population were insignificant.

conclusionsTargeting a PaO TRIAL REGISTRATION NUMBER: ClinicalTrials.gov number, NCT03174002. Date of registration: June 2, 2017.

Indexed as

COVID-19HumansIntensive Care UnitsLungOxygen Inhalation TherapyRespiration, ArtificialSARS-CoV-2intensive care unitsoxygen inhalation therapyrandomized controlled trialrespiratory insufficiencysevere acute respiratory syndrome coronavirus 2

Identifiers

PMID34425016
PMCPMC8653379
OpenAlexW3194619316

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.